In today’s IP intensive marketplace, your IP is your startups’ exit strategy. It provides an asset for a larger player to license and integrate into their product or technologies as part of a broader IP strategy. At some point during the licensing term, if your IP is generating significant royalties, your licensing partner will most likely want to buy you out.
Sourced through Scoop.it from: www.medtechdirectory.com
Got intellectual property? IP is clearly a startup’s prime exit strategy. Learn how to bake it in from the beginning by contacting EGS for a courtesy consultation.